Data from 1,028 people vaccinated with TAK-003 in Catalonia suggests the dengue vaccine has a good tolerability profile in routine clinical practice among travelers from regions where dengue is not endemic. The findings come from a study led by the Barcelona Institute for Global Health, together with Hospital Clínic Barcelona, and published in The Lancet Regional Health Europe.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗